Information about Novartis Pharma
My details
*
*
*

Company information

Status
Active

KVK number

09016995

VAT Number

NL 001820096 B01
Established
10-02-1948
Last balance sheet year
2025
Company size
Big 236 FTE
RSIN number
001820096
Trade names
  • Novartis
Principal activity
Groothandel in farmaceutische producten
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Novartis Pharma

2025 2024 2023 2022
Profit/Loss 14.062.000 -13,83% 16.319.000 9,95% 14.842.000 23,55% 12.013.000
Turnover 371.143.000 -12,52% 424.264.000 10,04% 385.552.000 11,54% 345.671.000
Equity 55.148.000 34,23% 41.086.000 5,98% 38.767.000 62,04% 23.925.000
Gross margin 83.344.000 -2,98% 85.906.000 3,73% 82.820.000 -2,26% 84.739.000
Employees 236 232 240 270

Frequently asked questions

What is the KVK number of Novartis Pharma?
The KVK number of Novartis Pharma is 09016995
What is the VAT number of Novartis Pharma?
The VAT number of Novartis Pharma is NL 001820096 B01.
Wat is the PEPPOL ID of Novartis Pharma?
There is no information available about the PEPPOL ID of Novartis Pharma or the company is not yet registered on the PEPPOL network.
When was Novartis Pharma founded?
Novartis Pharma was founded on 10-02-1948.
What is the address of Novartis Pharma?
The current registered office of Novartis Pharma is located at Haaksbergweg 16, 1101 BX Amsterdam.
When was the last time Novartis Pharma filed their annual financial statements?
The most recent financial statements of Novartis Pharma were filed on 31-12-2025.
How many employees does Novartis Pharma have?
There are 236 FTEs working at Novartis Pharma according to the staff figures in the most recent financial statements.
What is the annual turnover of Novartis Pharma?
At the time of its most recent financial statements, Novartis Pharma recorded a total turnover of €371.143.000,00.